4//SEC Filing
Duncan Jason 4
Accession 0001610717-23-000398
CIK 0001885522other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:16 PM ET
Size
5.4 KB
Accession
0001610717-23-000398
Insider Transaction Report
Form 4
Duncan Jason
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-12-11+400,000→ 400,000 totalExercise: $12.97Exp: 2033-12-10→ Common Stock (400,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Documents
Issuer
Neumora Therapeutics, Inc.
CIK 0001885522
Entity typeother
Related Parties
1- filerCIK 0001741553
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:16 PM ET
- Size
- 5.4 KB